Form 4 for VCYT VERACYTE, INC.
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001384101-25-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-03 | 2025-02-27+ | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $34.12 | -22.4K | 97.3K | -19% | -$765.1K |
| 2025-03-03 | 2025-02-27 | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | A - Grant | $0.00 | +30.6K | 113.0K | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-02 | F | D | 6,754 | $34.76 | 90,577 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-27 | F | D | 15,672 | $33.84 | 97,331 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-27 | A | A | 30,589 | $0.00 | 113,003 | D | — | — |